Spire Healthcare deal reflects trend of major healthcare businesses leaving public markets
Posted on
Britain’s second-largest provider of private healthcare, Spire Healthcare, moves from the public to the private market following a £1.03 billion acquisition. This deal reflects a growing trend of major healthcare business leaving public markets.
Interested in learning more about investment for healthtech innovation? Sign up to the HIN Investment Update.
The £1.03 billion acquisition of Spire Healthcare by a consortium led by Toscafund Asset Management is one of the most significant UK healthcare services transactions of recent years.
Spire is Britain’s second-largest provider of private healthcare with 38 private hospitals and over 55 clinics across England, Wales and Scotland, which together provided care to over 1.36 million patients in 2025.
Under the agreed terms, the consortium, comprising of Toscafund, Three Hills Capital Partners and Ares Management, acquired Spire for 250p per share in cash. The offer represents a 66.2% premium to Spire’s undisturbed share price and values the business at an implied enterprise value of approximately £2.3 billion.
The consortium, led by hedge fund veteran Martin Hughes, intends to support investment in Spire’s core hospital operations alongside technology, artificial intelligence (AI) and digital patient services. The deal also highlights the continued willingness of private equity and private credit investors to deploy significant capital into healthcare, £1.2 billion of debt financing supporting the transaction alongside substantial equity commitments.
A particularly notable aspect of the announcement is the leadership transition. Following nine years as CEO, Justin Ash will step down and be succeeded on an interim basis by Sir David Sloman.
Sir David is one of the UK’s most respected healthcare leaders, having previously served as Chief Operating Officer of NHS England, Regional Director for NHS England and NHS Improvement in London, and Chief Executive of the Royal Free London NHS Foundation Trust. His appointment brings deep operational and system leadership experience at a time when private healthcare providers are playing a greater role in supporting NHS capacity and patient access.
While the transaction represents an attractive outcome for shareholders, it also marks the loss of another significant healthcare company from the London Stock Exchange. Spire has been one of the UK’s largest listed healthcare service providers, and its move into private ownership further reduces the number of sizeable healthcare investment opportunities available to public market investors.
The deal therefore presents a mixed picture: strong investor confidence in healthcare, but a continuing trend of major healthcare businesses leaving public markets. These themes will be explored in an upcoming HIN Investor Panel webinar, delivered by the Health Innovation Network South London and Hill Dickinson. During the session, founders, brokers and advisers will discuss recent interest in the Alternative Investment Market (AIM) as for innovative companies looking to attract investment. We’ll also be joined by Cambridge Cognition, who will share first-hand insights and lessons learned from their experience of listing on AIM. As well as Cavendish to explain the process from the viewpoint of a broker.
The Alternative Investment Market (AIM) webinar will run from 12:00pm – 1:00pm on Monday 9 November
Sign up to reserve your space on this HIN Investor Panel webinar

Subscribe to the HIN Investment Update for key investment news, exclusive insights from the HIN’s investor network, and the latest opportunities and events. Ideal for growing healthtech companies, as well as funders and investors shaping the health innovation ecosystem.



